FDAnews Drug Daily Bulletin

KURVE TECHNOLOGY ANNOUNCES AGREEMENT WITH DARA BIOSCIENCES

March 30, 2006
A A

Kurve Technology, Inc., a leader in nasal drug delivery devices, today announced the signing of an agreement with development-stage pharmaceutical company DARA BioSciences, Inc. (DBI). DBI focuses on the treatment of metabolic diseases, central nervous system disorders and medical devices.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-29-2006/0004328995&EDATE=)